Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study.
Kirchhof P, Bakhai A, de Asmundis C, de Groot JR, Deharo JC, Kelly P, Lopez-de-Sa E, Monteiro P, Fronk EM, Lamparter M, Laeis P, Smolnik R, Steffel J, Waltenberger J, Weiss TW, De Caterina R.
Kirchhof P, et al. Among authors: weiss tw.
Int J Cardiol. 2024 Apr 30:132118. doi: 10.1016/j.ijcard.2024.132118. Online ahead of print.
Int J Cardiol. 2024.
PMID: 38697397